Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EHR Meaningful Use Could See Optional Items Become Requirements In Stage 2

This article was originally published in The Pink Sheet Daily

Executive Summary

Preliminary objectives of next round of demonstrating meaningful use of electronic health records also include greater emphasis on clinical decision support and health information exchange, as expected.

You may also be interested in...



Medical Groups Call For More Flexibility, Time In EHR Stage 2 Meaningful Use

A group of 35 medical organizations, including the American Medical Association, are calling for more flexibility and time in meeting criteria for meaningful use of electronic health records as the HHS Office of the National Coordinator for Health Information Technology continues to develop stage 2 criteria.

Medical Groups Call For More Flexibility, Time In EHR Stage 2 Meaningful Use

A group of 35 medical organizations, including the American Medical Association, are calling for more flexibility and time in meeting criteria for meaningful use of electronic health records as the HHS Office of the National Coordinator for Health Information Technology continues to develop stage 2 criteria.

CMS Reveals Early Registration Numbers For Electronic Health Record Incentives

Agency calls interest "strong" while National Coordinator for Health Information Technology Blumenthal calls 2011 "the age of meaningful use of health information."

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel